University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing

Not Applicable

Completed

Conditions: HIV

Interventions: Behavioral: Crowdsourced Video
Behavioral: Conventional Video

First Posted Date: 2014-09-25

Last Posted Date: 2017-02-10

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 721

Registration Number: NCT02248558

Locations: 🇨🇳
UNC Project-China, Guangzhou, China

Detection of Brown Adipose Tissue by Magnetic Resonance Imaging

Recruiting

Conditions: Obesity

First Posted Date: 2014-09-11

Last Posted Date: 2023-07-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 40

Registration Number: NCT02237872

Locations: 🇺🇸
Biomedical Research Imaging Center, Chapel Hill, North Carolina, United States

Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults

Not Applicable

Completed

Conditions: Alcohol Abuse

Interventions: Behavioral: Brief Negotiated Interview
Behavioral: General Health Information

First Posted Date: 2014-09-10

Last Posted Date: 2017-07-12

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 222

Registration Number: NCT02236494

Locations: 🇺🇸
UNC Hospitals Emergency Department, Chapel Hill, North Carolina, United States

Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

Phase 1

Completed

Conditions: Non-alcoholic Steatohepatitis

Interventions: Drug: Technetium Tc 99M Mebrofenin

First Posted Date: 2014-09-09

Last Posted Date: 2017-05-05

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 21

Registration Number: NCT02235233

Locations: 🇺🇸
UNC Hospitals, Chapel Hill, North Carolina, United States

Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis

Completed

Conditions: ALS

First Posted Date: 2014-08-29

Last Posted Date: 2018-10-17

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 21

Registration Number: NCT02228915

Locations: 🇺🇸
UNC Neurology ALS clinic, Chapel Hill, North Carolina, United States

Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD?

Phase 1

Completed

Conditions: Acid Reflux
GERD
Gastroesophageal Reflux Disease
Reflux

Interventions: Drug: Quercetin

First Posted Date: 2014-08-27

Last Posted Date: 2016-12-20

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 26

Registration Number: NCT02226484

Locations: 🇺🇸
UNC Chapel Hill, Chapel Hill, North Carolina, United States

Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study

Phase 1

Recruiting

Conditions: Obesity

Interventions: Drug: Xenon

First Posted Date: 2014-08-19

Last Posted Date: 2023-07-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 32

Registration Number: NCT02220426

Locations: 🇺🇸
Biomedical Research Imaging Center, Chapel Hill, North Carolina, United States

Fabrication of a Definitive Cad/Cam Titanium Abutment Prior to Guided Surgery: a Pilot Study.

Not Applicable

Completed

Conditions: Single Edentulous Space

Interventions: Device: abutment margin 0.5 mm subgingival
Device: abutment margin 1.5 mm subgingival

First Posted Date: 2014-08-18

Last Posted Date: 2018-07-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 22

Registration Number: NCT02218541

Locations: 🇺🇸
Graduate Prosthodontic Clinic, Dept. of Prosthodontics, UNC School of Dentistry, Chapel Hill, North Carolina, United States

Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

Completed

Conditions: Human Immunodeficiency Virus

Interventions: Drug: Raltegravir
Drug: Dolutegravir
Procedure: Colonoscopy with biopsy

First Posted Date: 2014-08-18

Last Posted Date: 2018-12-26

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 20

Registration Number: NCT02218320

Locations: 🇺🇸
Clinical and Translational Research Center, UNC Hospitals, Chapel Hill, North Carolina, United States

Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

Terminated

Conditions: Brain Injury
Hyponatremia

Interventions: Drug: Tolvaptan

First Posted Date: 2014-08-13

Last Posted Date: 2016-09-08

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 1

Registration Number: NCT02215148

Locations: 🇺🇸
Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
University of North Carolina Hospitals, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy